Literature DB >> 7085873

Studies on a family with combined functional deficiencies of vitamin K-dependent coagulation factors.

G H Goldsmith, R E Pence, O D Ratnoff, D J Adelstein, B Furie.   

Abstract

Two siblings with m ild hemorrhagic symptoms had combined functional deficiencies of vitamin K-dependent clotting factors. Prothrombin (0.18-0.20 U/ml) and Stuart factor (Factor X, 0.18-0.20 U/ml) and Stuart factor (Factor X, 0.18-0.20 U/ml) were most severely affected. Antigenic amounts of affected coagulation factors were normal and normal generation of thrombin activity occurred in the patients' plasmas after treatment with nonophysiologic activators that do not require calcium for prothrombin activation. Hepatobilary disease, malabsorptive disorders, and plasma warfarin were not present. Both parents had normal levels of all coagulation factors. The patients' plasmas contained prothrombin that reacted both with antibody directed against des-gamma-carboxyprothrombin and native prothrombin. Crossed immunoelectrophoresis of patients' plasmas and studies of partially purified patient prothrombin suggested the presence of a relatively homogeneous species of dysfunctional prothrombin, distinct from the heterologous species found in the plasma of warfarin-treated persons. These studies are most consistent with a posttranslational defect in hepatic carboxylation of vitamin K-dependent factors. This kindred uniquely possesses an autosomal recessive disorder of vitamin K-dependent factor formation that causes production of an apparently homogeneous species of dysfunctional prothrombin; the functional deficiencies in clotting factors are totally corrected by oral or parenteral administration of vitamin K1.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7085873      PMCID: PMC370197          DOI: 10.1172/jci110564

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  Defective esterase and kinin-forming activity in human Fletcher trait plasma. A fraction rich in kallikreinlike activity.

Authors:  V H Donaldson; H Saito; O D Ratnoff
Journal:  Circ Res       Date:  1974-05       Impact factor: 17.367

2.  [Comparative study of the levels of staphylocoagulase cofactor (coagulase reacting factor) and of factor II (prothrombin) in various conditions].

Authors:  J P Soulier; O Prou-Wartelle
Journal:  Nouv Rev Fr Hematol       Date:  1966 Sep-Oct

3.  Defective activation of clotting, fibrinolytic, and permeability-enhancing systems in human Fletcher trait plasma.

Authors:  H Saito; O D Ratnoff; V H Donaldson
Journal:  Circ Res       Date:  1974-05       Impact factor: 17.367

4.  Crossed immunoelectrophoresis.

Authors:  B Weeke
Journal:  Scand J Immunol Suppl       Date:  1973

5.  The hereditary transmission of congenital 'true' hypoprothrombinaemia.

Authors:  A Girolami
Journal:  Br J Haematol       Date:  1971-12       Impact factor: 6.998

6.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

7.  The specific Assay of prothrombin using the Taipan snake venom.

Authors:  K W Denson; R Borrett; R Biggs
Journal:  Br J Haematol       Date:  1971-08       Impact factor: 6.998

8.  Congenital combined deficiency of coagulation factors II, VII, IX and X. Report of a case.

Authors:  C W McMillan; H R Roberts
Journal:  N Engl J Med       Date:  1966-06-09       Impact factor: 91.245

9.  Partial purification of plasma thromboplastin antecedent (factor XI) and its activation by trypsin.

Authors:  H Saito; O D Ratnoff; J S Marshall; J Pensky
Journal:  J Clin Invest       Date:  1973-04       Impact factor: 14.808

10.  Fibrinogen Cleveland II. An abnormal fibrinogen with defective release of fibrinopeptide A.

Authors:  E D Crum; J R Shainoff; R C Graham; O D Ratnoff
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

View more
  10 in total

1.  Compound heterozygosity of novel missense mutations in the gamma-glutamyl-carboxylase gene causes hereditary combined vitamin K-dependent coagulation factor deficiency.

Authors:  Dhouha Darghouth; Kevin W Hallgren; Rebecca L Shtofman; Amel Mrad; Youssef Gharbi; Ahmed Maherzi; Radhia Kastally; Sophie LeRicousse; Kathleen L Berkner; Jean-Philippe Rosa
Journal:  Blood       Date:  2006-05-23       Impact factor: 22.113

2.  Co-existent pseudoxanthoma elasticum and vitamin K-dependent coagulation factor deficiency: compound heterozygosity for mutations in the GGCX gene.

Authors:  Qiaoli Li; Leon J Schurgers; Ann C M Smith; Maria Tsokos; Jouni Uitto; Edward W Cowen
Journal:  Am J Pathol       Date:  2008-12-30       Impact factor: 4.307

3.  Familial deficiency of vitamin K-dependent clotting factors.

Authors:  B W Weston; P E Monahan
Journal:  Haemophilia       Date:  2008-11       Impact factor: 4.287

Review 4.  Laboratory evaluation of a bleeding patient.

Authors:  R O Wallerstein
Journal:  West J Med       Date:  1989-01

Review 5.  Hereditary combined deficiency of the vitamin K-dependent clotting factors.

Authors:  Mariasanta Napolitano; Guglielmo Mariani; Mario Lapecorella
Journal:  Orphanet J Rare Dis       Date:  2010-07-14       Impact factor: 4.123

6.  Association of congenital deficiency of multiple vitamin K-dependent coagulation factors and the phenotype of the warfarin embryopathy: clues to the mechanism of teratogenicity of coumarin derivatives.

Authors:  R M Pauli; J B Lian; D F Mosher; J W Suttie
Journal:  Am J Hum Genet       Date:  1987-10       Impact factor: 11.025

7.  γ-Glutamyl carboxylase mutations differentially affect the biological function of vitamin K-dependent proteins.

Authors:  Zhenyu Hao; Da-Yun Jin; Xuejie Chen; Leon J Schurgers; Darrel W Stafford; Jian-Ke Tie
Journal:  Blood       Date:  2021-01-28       Impact factor: 25.476

Review 8.  GGCX-Associated Phenotypes: An Overview in Search of Genotype-Phenotype Correlations.

Authors:  Eva Y G De Vilder; Jens Debacker; Olivier M Vanakker
Journal:  Int J Mol Sci       Date:  2017-01-25       Impact factor: 5.923

9.  Human endothelial cells and fibroblasts express and produce the coagulation proteins necessary for thrombin generation.

Authors:  Clay T Cohen; Nancy A Turner; Joel L Moake
Journal:  Sci Rep       Date:  2021-11-08       Impact factor: 4.379

10.  Suspected vitamin K-dependent coagulation factor deficiency in pregnancy: A case report.

Authors:  Mariam Ayyash; Meera Chitlur; Johannes Oldenburg; Majid Shaman
Journal:  Case Rep Womens Health       Date:  2022-04-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.